Company Introduction

Welcome to PharmAlliance International Labs Private Limited, where innovation meets patient care in the pursuit of neurological wellness. As a trusted leader in the pharmaceutical industry, we take pride in introducing our latest breakthrough: Ropinirole Tablets. With a dedicated commitment to enhancing neurological health, we strive to improve the quality of life for individuals affected by Parkinson’s disease and Restless Legs Syndrome (RLS).

Understanding Ropinirole: A Targeted Neurological Solution

Drug Classification: Dopamine Agonist Therapy

🔬 Ropinirole belongs to the dopamine agonist class of medications, a critical advancement in neurological treatment.

✔ Mechanism of Action:

• Ropinirole mimics dopamine, a key neurotransmitter responsible for motor function regulation.
• By stimulating dopamine D2 and D3 receptors in the brain’s basal ganglia, it helps restore neurotransmitter balance, reducing symptoms of Parkinson’s disease and RLS.
• As a non-ergot dopamine agonist, Ropinirole minimizes the risk of fibrosis-related complications seen with older ergot-derived dopamine agonists.

✔ Key Benefits:
✅ Effective monotherapy in early-stage Parkinson’s disease
✅ Adjunctive therapy with Levodopa in advanced cases
✅ Clinically proven relief for Restless Legs Syndrome (RLS)

Tailored Formulations for Optimized Treatment

At PharmAlliance, we prioritize patient-centric solutions by offering Ropinirole Tablets in precise formulations:

Available Strengths:

💊 0.25 mg – Initial dose for gradual titration
💊 1 mg – Moderate dose for symptom control
💊 2 mg – Higher dose for advanced symptom management

Packaging & Convenience:

📦 Blister packs of 20 tablets – Ensuring hygienic storage and accurate dosing
📦 Compact and easy-to-carry design – Promoting treatment adherence

With reliable dosing options, healthcare providers can personalize treatment plans, ensuring maximum efficacy while minimizing side effects.

Indications: A Comprehensive Solution for Neurological Disorders

Ropinirole Tablets are clinically indicated for the treatment of:

1. Parkinson’s Disease

🔹 Monotherapy in early-stage Parkinson’s disease
🔹 Adjunct therapy in advanced cases (combined with Levodopa)
🔹 Targets motor symptoms, including:
✔ Tremors
✔ Rigidity
✔ Bradykinesia (slow movements)

2. Restless Legs Syndrome (RLS)

🔹 Provides relief from uncontrollable leg movements
🔹 Reduces nighttime discomfort, improving sleep quality

✔ Clinically proven to improve mobility, reduce discomfort, and enhance overall neurological well-being

Usage and Dosage: Personalized Treatment Plans

Administration Guidelines

✔ Oral intake – Can be taken with or without food
✔ Follow prescribed dosage for gradual titration
✔ Dosing adjustments based on patient response and tolerance

Standard Dosage Recommendations

💡 Titration Strategy: Start at a low dose and increase gradually to optimize benefits and minimize side effects.

💡 Missed Dose? Take it as soon as remembered, but skip if close to the next dose. Do not double dose.

Pharmacokinetics & Pharmacodynamics: How Ropinirole Works

✔ Absorption: Rapidly absorbed after oral administration
✔ Peak Plasma Levels: Achieved within 1–2 hours
✔ Metabolism: Extensively metabolized in the liver (CYP1A2 enzyme system)
✔ Excretion: Primarily via the kidneys

📊 Pharmacodynamic Benefits:
🔹 Enhances dopaminergic activity in the brain
🔹 Improves motor function and neurological coordination
🔹 Provides sustained symptom relief with minimal dose fluctuations

Potential Side Effects: Ensuring Safe Usage

While Ropinirole is well-tolerated, patients should be aware of potential side effects:

Common Side Effects (Mild & Temporary):

✔ Nausea & dizziness – Typically improves with continued use
✔ Drowsiness & fatigue – Avoid operating heavy machinery if affected
✔ Orthostatic hypotension – Prevent by rising slowly from sitting/lying positions

Rare but Serious Side Effects:

❗ Hallucinations or confusion – Monitor in elderly patients
❗ Compulsive behaviors (e.g., gambling, binge eating, hypersexuality) – Linked to dopaminergic overstimulation
❗ Dyskinesias (uncontrolled movements) – More common when combined with Levodopa

🚨 Seek immediate medical attention for:

• Severe allergic reactions (swelling, difficulty breathing)
• Unusual sleep attacks (sudden, uncontrollable sleep episodes)

🔹 Regular follow-ups with a healthcare provider ensure safe and effective treatment.

Why Choose PharmAlliance’s Ropinirole Tablets?

✔ Precision Formulations – Available in optimized strengths (0.25 mg, 1 mg, 2 mg)
✔ High-Quality Manufacturing – Produced under strict GMP standards
✔ Reliable Packaging – Blister packs for accurate dosing and storage
✔ Proven Efficacy – Clinically tested for Parkinson’s disease & RLS
✔ Enhanced Patient Compliance – Well-tolerated, once-daily dosing

🔹 At PharmAlliance, we are committed to delivering pharmaceutical excellence, ensuring every dose meets the highest standards of safety and effectiveness.

Experience the PharmAlliance Difference

Discover the transformative benefits of Ropinirole, exclusively from PharmAlliance International Labs. Your neurological health is our priority, and we are dedicated to providing innovative solutions for a better quality of life.

📧 Email: info@Pharmalliance.pk
📞 Contact Number: +92 333 9261419
🌐 Website: www.PharmAlliance.pk

For product inquiries, medical guidance, or partnership opportunities, contact us today! 🚀